Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
51,365,525
-
Share change
-
-590,155
-
Total reported value
-
$166,883,340
-
Put/Call ratio
-
35%
-
Price per share
-
$3.25
-
Number of holders
-
98
-
Value change
-
+$384,948
-
Number of buys
-
35
-
Number of sells
-
45
Institutional Holders of IMMUNOMEDICS INC - COM (IMMU) as of Q3 2016
As of 30 Sep 2016,
IMMUNOMEDICS INC - COM (IMMU) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,365,525 shares.
The largest 10 holders included
venBio Select Advisor LLC, ACUTA CAPITAL PARTNERS, LLC, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., Tourbillon Capital Partners, L.P., Ghost Tree Capital, LLC, J. Goldman & Co LP, and BALYASNY ASSET MANAGEMENT LLC.
This page lists
98
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.